USPTO serial 79302219
XPHELYUM
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Feb 22, 2022
- Examiner
- CLARK, ANDREW T
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with XPHELYUM?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Biological preparations for medical use for the treatment of conditions, ailments, diseases and disorders of the electrical nervous system; Biological preparations for medical use for the treatment of inflammatory conditions, autoimmune diseases, inflammatory bowel disease, arthritis, migraines, metabolic disorders, obesity, diabetes, paralysis, sensory disorders and impairments, hypertension, cancer, cardiac rhythm management, sleep apnea, Parkinson disease, Alzheimer's disease, dystonia, neurodegenerative diseases, obsessive compulsive disorder, depressive disorders, arrhythmias, epilepsy, incontinence and chronic pain; biological preparations for veterinary use for the treatment of conditions, ailments, diseases and disorders of the electrical nervous system; chemical preparations for medical use for the treatment of conditions, ailments, diseases and disorders of the electrical nervous system; chemical preparations for medical use for the treatment of inflammatory conditions, autoimmune diseases, inflammatory bowel disease, arthritis, migraines, metabolic disorders, obesity, diabetes, paralysis, sensory disorders and impairments, hypertension, cancer, cardiac rhythm management, sleep apnea, Parkinson disease, Alzheimer's disease, dystonia, neurodegenerative diseases, obsessive compulsive disorder, depressive disorders, arrhythmias, epilepsy, incontinence and chronic pain; biological preparations for veterinary use for the treatment of conditions, ailments, diseases and disorders of the electrical nervous system; chemical preparations for pharmaceutical use, namely for the treatment of conditions, ailments, diseases and disorders of the electrical nervous system; chemical preparations for veterinary use, namely, for the treatment of conditions, ailments, diseases and disorders of the electrical nervous system; chemical reagents for medical or veterinary use; chemical-pharmaceutical preparations for the treatment of conditions, ailments, diseases and disorders of the electrical nervous system; drugs for medical use for the treatment of conditions, ailments, diseases and disorders of the electrical nervous system; drugs for medical use for the treatment of inflammatory conditions, autoimmune diseases, inflammatory bowel disease, arthritis, migraines, metabolic disorders, obesity, diabetes, paralysis, sensory disorders and impairments, hypertension, cancer, cardiac rhythm management, sleep apnea, Parkinson disease, Alzheimer's disease, dystonia, neurodegenerative diseases, obsessive compulsive disorder, depressive disorders, arrhythmias, epilepsy, incontinence and chronic pain; medicines for human medicine for the treatment of conditions, ailments, diseases and disorders of the electrical nervous system; pharmaceutical preparations for the treatment of conditions, ailments, diseases and disorders of the electrical nervous system; pharmaceutical products for the treatment of conditions, ailments, diseases and disorders of the electrical nervous system; pharmaceutical preparations and pharmaceutical products for the treatment of inflammatory conditions, autoimmune diseases, inflammatory bowel disease, arthritis, migraines, metabolic disorders, obesity, diabetes, paralysis, sensory disorders and impairments, hypertension, cancer, cardiac rhythm management, sleep apnea, Parkinson disease, Alzheimer's disease, dystonia, neurodegenerative diseases, obsessive compulsive disorder, depressive disorders, arrhythmias, epilepsy, incontinence and chronic pain | ACTIVE | — |
| 009 | Electric apparatus for switching, namely, electric switches; data processing apparatus; intercommunication apparatus, namely, telephones incorporating intercommunication systems; measuring apparatus, namely, analyzers for measuring, testing and analyzing blood and other bodily fluids and temperature sensors used in the medical field to measure temperature of medical solutions, testing and analyzing heartbeat, sensors measuring body functions; monitoring apparatus, other than for medical use, namely, electronic monitors and monitor modules for monitoring electric current and electrical signals; apparatus and instruments for physics, namely, electrodes , sensors collecting physical signals; precision measuring apparatus, namely, lasers for measuring; remote control apparatus, namely, remote control transmitter for radio-controlled devices; chips being integrated circuits; integrated circuits; interfaces for computers; microprocessors; Processors being central processing units, central processing units for processing information, data, sound, speech or images; telecommunications transmitters; smart rings; telecommunication apparatus in the form of jewelry, namely, smart rings; Wearable computers in the nature of smart glasses and smart watches | ACTIVE | — |
| 010 | Medical apparatus and instruments for stimulating the nervous system; veterinary apparatus and instruments for stimulating the nervous system | ACTIVE | — |
| 042 | Industrial research in biology; industrial research in chemistry; conducting clinical trials for others; medical research; scientific research; industrial research relating to technology; industrial research in the field of physics; industrial research in the field of telecommunication technology | ACTIVE | — |
| 044 | Health care services; telemedicine services; therapy services, namely, physical therapy and mental health therapy services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by XPHELYUM
- Other trademarks owned by XPHELYUM
- Other trademarks owned by XPHELYUM
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named XPHELYUM
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 16, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jul 27, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jul 27, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| May 22, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Feb 22, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 7, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 7, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 6, 2021 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Nov 17, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Nov 17, 2021 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Nov 17, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 2, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 14, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 14, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 14, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 30, 2021 | RFNT | REFUSAL PROCESSED BY IB | — |
| May 8, 2021 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| May 5, 2021 | RFRR | REFUSAL PROCESSED BY MPU | — |
| May 5, 2021 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| May 4, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 24, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 19, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 15, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 14, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |